Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anal lesions: any significant prognosis in Crohn's disease?
Siproudhis L, Mortaji A, Mary JY, Juguet F, Bretagne JF, Gosselin M. Siproudhis L, et al. Among authors: bretagne jf. Eur J Gastroenterol Hepatol. 1997 Mar;9(3):239-43. doi: 10.1097/00042737-199703000-00004. Eur J Gastroenterol Hepatol. 1997. PMID: 9096423
NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.
Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J. Heresbach D, et al. Among authors: bretagne jf. Eur J Gastroenterol Hepatol. 2004 Jan;16(1):55-62. doi: 10.1097/00042737-200401000-00009. Eur J Gastroenterol Hepatol. 2004. PMID: 15095853
Anismus and biofeedback: who benefits?
Siproudhis L, Dautrème S, Ropert A, Briand H, Renet C, Beusnel C, Juguet F, Rabot AF, Bretagne JF, Gosselin M. Siproudhis L, et al. Among authors: bretagne jf. Eur J Gastroenterol Hepatol. 1995 Jun;7(6):547-52. Eur J Gastroenterol Hepatol. 1995. PMID: 7552638
Fecal incontinence with normal anal canal pressures: where is the pitfall?
Siproudhis L, Bellissant E, Pagenault M, Mendler MH, Allain H, Bretagne JF, Gosselin M. Siproudhis L, et al. Among authors: bretagne jf. Am J Gastroenterol. 1999 Jun;94(6):1556-63. doi: 10.1111/j.1572-0241.1999.01144.x. Am J Gastroenterol. 1999. PMID: 10364025 Clinical Trial.
Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Bouguen G, et al. Among authors: bretagne jf. Clin Gastroenterol Hepatol. 2013 Aug;11(8):975-81.e1-4. doi: 10.1016/j.cgh.2012.12.042. Epub 2013 Jan 30. Clin Gastroenterol Hepatol. 2013. PMID: 23376316 Free article.
Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.
Bouguen G, Laharie D, Nancey S, Hebuterne X, Flourie B, Filippi J, Roblin X, Trang C, Bourreille A, Babouri A, Bretagne JF, Siproudhis L, Peyrin-Biroulet L. Bouguen G, et al. Among authors: bretagne jf. Inflamm Bowel Dis. 2015 May;21(5):1047-53. doi: 10.1097/MIB.0000000000000359. Inflamm Bowel Dis. 2015. PMID: 25803504
Crohn's disease: is there any link between anal and luminal phenotypes?
Wallenhorst T, Brochard C, Bretagne JF, Bouguen G, Siproudhis L. Wallenhorst T, et al. Among authors: bretagne jf. Int J Colorectal Dis. 2016 Feb;31(2):307-11. doi: 10.1007/s00384-015-2390-8. Epub 2015 Sep 26. Int J Colorectal Dis. 2016. PMID: 26410258 Free article.
274 results